HN
Himalaya Nutravedics India IPO Listing Price, Gain & Allotment
Listed
SME IPO
BSE SME
Listed 29 Sep 2026
· updated 1 month ago
Price band
₹100 – 106
GMP
—
Est. listing price—
Est. listing gain—
Issue size₹26.5 Cr
Himalaya Nutravedics India IPO Details
Open DateTue, 22 Sep 2026
Close DateThu, 24 Sep 2026
Listing DateTue, 29 Sep 2026
Listing AtBSE SME
Price Band₹100 – 106 per share
Lot Size1,200 shares
Min. Investment₹2,54,400
Issue Size₹26.5 Cr
Himalaya Nutravedics India IPO Dates & Timeline
Tentative dates follow SEBI's T+3 listing timelineIPO Opens
Tue, 22 Sep
IPO Closes
Thu, 24 Sep
Basis of Allotment
Fri, 25 Sep
Tentative
Refunds Initiated
Mon, 28 Sep
Tentative
Shares Credited to Demat
Mon, 28 Sep
Tentative
Listing Date
Tue, 29 Sep
Himalaya Nutravedics India IPO GMP Today
All IPO GMP
GMP today
—
Est. listing price
—
Est. gain %
—
Est. profit / lot
—
GMP for this IPO is not available yet. It usually appears a few days before the issue opens.
Try the GMP calculator · What is GMP? · GMP of all IPOs
Final visitor sentiment
Visitor opinion poll, not investment advice.
Himalaya Nutravedics India IPO Listing Price & Gain
Issue price₹106
Listing price (BSE)₹118
Listing gain+11.32%
Listing-day close₹122.9 (+15.9%)
Himalaya Nutravedics India IPO Allotment Status
The registrar for this IPO is KFin Technologies. You can also check on the exchange websites using your PAN or application number.
New to this? Read how to check IPO allotment status or see all IPOs awaiting allotment.
Himalaya Nutravedics India IPO Lot Size & Minimum Investment
At upper price band of ₹106| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2,400 | ₹2,54,400 |
| Retail (Max) | 2 | 2,400 | ₹2,54,400 |
| S-HNI (Min) | 3 | 3,600 | ₹3,81,600 |
| S-HNI (Max) | 7 | 8,400 | ₹8,90,400 |
| B-HNI (Min) | 8 | 9,600 | ₹10,17,600 |
Himalaya Nutravedics India IPO analysis: what the numbers say
The ₹26.5 Cr issue is entirely a fresh issue, so all the money goes to the company. Promoter holding falls from 95.14% to 68.13% after the issue. At the upper price band the issue values the company at a post-issue P/E of 9.
Revenue rose from ₹14.43 Cr in FY24 to ₹43.12 Cr in FY26, a compound annual growth of 72.9%. Profit after tax grew from ₹0.43 Cr to ₹7.39 Cr. That is a net profit margin of 17.1% in FY26. Borrowings were 0.31 times net worth at the end of FY26.
Himalaya Nutravedics India listed at ₹118 on 29 Sep 2026, +11.3% against the issue price of ₹106. It closed the first day at ₹122.9 (+15.9%).
Worked out by IPO Darbaar from the offer document, exchange data and the latest GMP. For information only, not a recommendation.
Himalaya Nutravedics India IPO Issue Structure
Fresh issue ₹25 Cr (100%)
Offer for sale — (0%)
Face value₹10 / share
Market cap (post issue)—
Promoter holding (pre)95.14%
Promoter holding (post)68.13%
- Promoters
- Rohit Asawa, Divya Asawa, Chanda Asawa, Rama Raju Penmatsa
- Book running lead managers
- Nirbhay Capital Services Pvt. Ltd.
Objects of the Himalaya Nutravedics India IPO
- Funding Working Capital Requirements. ~ Rs. 13.75 Cr.
- Business Development and Digital Marketing Activities. ~ Rs. 7.50 Cr.
- General Corporate Purposes.
Himalaya Nutravedics India IPO Strengths & Risks
Strengths
- Geographical spread across India.
- Long-standing connections with suppliers and clients.
- Integrated production capabilities for many dosages.
- Physician acceptability is backed by product effectiveness.
Risks
- Incorporated in 2022, its shorter operating history may constrain institutional tie-ups and prescriber loyalty compared to established peers.
- Primary reliance on doctor-led and pharmacy-based channels limits direct-to-consumer reach and e-commerce penetration.
- Operating in AYUSH and nutraceutical segments requires continuous adherence to evolving FSSAI, AYUSH, and advertising regulations.
Himalaya Nutravedics India Financials
Restated, ₹ crore
FY24
FY25
FY26
Revenue Profit after tax
| Period ended | FY2431 Mar 2024 | FY2531 Mar 2025 | FY2631 Mar 2026 |
|---|---|---|---|
| Revenue | 14.43 | 21 | 43.12 |
| Profit after tax | 0.43 | 2.23 | 7.39 |
| Net worth | 1.34 | 6.75 | 16.38 |
| Total assets | 6.09 | 10.82 | 24.42 |
| Total borrowings | 3.24 | 1.76 | 5.13 |
| PAT margin | 2.98% | 10.62% | 17.14% |
Himalaya Nutravedics India Key Performance Indicators (KPIs)
P/E (post issue)9.04x
ROE63.87%
ROCE36.41%
RoNW45.12%
Debt / Equity0.31
About Himalaya Nutravedics India IPO
Himalaya Nutravedics India is an SME IPO worth ₹26.5 crore with a price band of ₹100 – 106 per share. The issue opens on 22 September 2026 and closes on 24 September 2026. Shares are expected to list on 29 September 2026 on BSE SME.
Himalaya Nutravedics India IPO under the SME IPO category is a book build issue of Rs. 26.50 Cr by Himalaya Nutravedics India Limited, which carries out third-party contract manufacturing for other Ayurvedic and nutraceutical businesses in addition to manufacturing, marketing, and distributing Ayurvedic and nutraceutical formulations in India. Its products come in a variety of dosage forms, such as tablets, liquid orals, hard and soft gelatin capsules, and medicated oils.
The products address a variety of therapeutic and wellness topics, including immunity, women's wellbeing, diabetic control, pain management, gut health, and cardiac and metabolic fitness.
Himalaya Nutravedics uses a hybrid business approach that combines contract production with its own branded products. The company's third-party manufacturing division offers formulation, manufacturing, packing, and delivery services in accordance with customer specifications, while its own-brand division creates, produces, and sells Ayurvedic and nutraceutical goods.
Himalaya Nutravedics India IPO: FAQs
What was the listing price of Himalaya Nutravedics India IPO?
Himalaya Nutravedics India listed at ₹118 on 29 Sep 2026, +11.3% against the issue price of ₹106. It closed the first day at ₹122.9 (+15.9%).
What is the price band of Himalaya Nutravedics India IPO?
The Himalaya Nutravedics India IPO price band is ₹100 – 106 per share and the issue size is ₹26.5 crore.
What is the lot size and minimum investment for Himalaya Nutravedics India IPO?
One lot of Himalaya Nutravedics India IPO has 1,200 shares. The minimum application for retail investors is 2 lots (2,400 shares), which costs ₹2,54,400 at the upper price band.
When does Himalaya Nutravedics India IPO open and close?
Himalaya Nutravedics India IPO opens for subscription on Tuesday, 22 September 2026 and closes on Thursday, 24 September 2026. Bids are accepted until 5 PM on the closing day.
What is the Himalaya Nutravedics India IPO allotment date?
The basis of allotment for Himalaya Nutravedics India IPO is expected to have been finalised on Friday, 25 September 2026, one working day after the issue closes (SEBI T+3 timeline).
How to check Himalaya Nutravedics India IPO allotment status?
Visit the website of the registrar, KFin Technologies, select Himalaya Nutravedics India IPO and search by PAN or application number. You can also check on the IPO allotment status page or on the BSE and NSE websites.
When is Himalaya Nutravedics India IPO listing date?
Himalaya Nutravedics India shares listed on BSE SME on Tuesday, 29 September 2026 at ₹118 per share.
Is Himalaya Nutravedics India a mainboard or SME IPO?
Himalaya Nutravedics India is an SME IPO, listing on the BSE SME platform. Individual investors must apply for at least two lots in SME IPOs.
Last updated 28 Sep 2026, 11:53 PM IST. GMP is unofficial and indicative; dates after the issue closes are tentative. Not investment advice.